Quoin Pharmaceuticals Ltd.

QNRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.90

-$0.16 (-2.27%)

At close: Sep 21, 2026, 4:00 PM ET

$6.90

$0 (0.00%)

Pre-market: Sep 22, 2026, 5:01 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-15.93M	-9.01M	-8.69M	-9.38M	-21.46M	-2.1M
Depreciation & Amortization	100K	100K	103.71K	104.04K	104.04K	104.04K
Stock-Based Compensation	1.15M	1.26M	1.09M	764.01K	n/a	n/a
Other Working Capital	-93.59K	-278.09K	41.42K	123.46K	-715.47K	47.04K
Other Non-Cash Items	-100.25K	-209.05K	-471.31K	127.07K	15.01M	378.33K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.24M	-2.14K	95.2K	-94.35K	632.33K	274.36K
Operating Cash Flow	-13.54M	-7.86M	-7.86M	-8.48M	-5.72M	-1.34M
Capital Expenditures	4	n/a	3.77	-250K	-625K	-125K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-12.36M	-17.25B	-18.04M	-9.9M	n/a	n/a
Sales Maturities Of Investments	8.05M	26.93B	20.23M	14.88B	n/a	n/a
Other Investing Acitivies	33.94K	-9.68B	5.64K	-14.88B	n/a	n/a
Investing Cash Flow	-4.28M	-1.89M	2.19M	-10.15M	-625K	-125K
Debt Repayment	n/a	-600K	-600K	-311.67K	3.48M	909.98K
Common Stock Repurchased	n/a	n/a	n/a	-14.82M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-65.27M	n/a	n/a
Other Financial Acitivies	-747.67K	-54.9K	-17.51K	64.77M	10.03M	1.02M
Financial Cash Flow	18.01M	10.97M	5.22M	14.01M	13.5M	1.79M
Net Cash Flow	194.75K	1.22M	-459.43K	-4.62M	7.16M	-4.92M
Free Cash Flow	-13.54M	-7.86M	-7.86M	-8.73M	-6.35M	-1.46M
Adj. Free Cash Flow	-14.69M	-9.12M	-8.96M	-9.49M	-6.35M	-1.46M
Maintenance CapEx	-4	n/a	-3.77	-104.04K	-104.04K	-104.04K
Growth CapEx	8	n/a	7.53	-145.96K	-520.96K	-20.96K
Owner Earnings	-13.54M	-7.86M	-7.86M	-8.58M	-5.82M	-1.44M